Johnson & Johnson reaches $700 million settlement in talc baby powder case

[C-40]

Johnson & Johnson reaches $700 million settlement in talc baby powder case​

Johnson & Johnson has agreed to pay $700 million in a nationwide settlement resolving allegations that it misled customers about the safety of its talcum-based powder products in its marketing. As part of the settlement, which is still pending judicial approval, the health products giant will permanently stop the manufacturing, promotion and sale of all of its baby powder and other body and cosmetic products that contain talcum powder. That includes Johnson's Baby Powder and Johnson & Johnson's Shower to Shower. The company decided to pull talc-based powders off the market in North America in 2020. J&J will make four settlement payments, starting at the end of July, to 42 states and Washington, D.C., according to the settlement. The $700 million settlement is the latest development in decade-long legal battles and investigations into links between cancer and the talc used in one of its best-known products. More than 50,000 claims have been filed against the company, mostly on behalf of women who developed ovarian cancer.

Click Here For Complete Story

 

[DevilMan]

No One Cares, and that was in February HAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAH

 

[C-40]

Media Center | Catch up on the latest Johnson & Johnson news and download the J&J logo and media assets here.​

Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the potential medicines of tomorrow. Therapeutic areas include: Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.

Click Here For Complete Story